Avacta enters research collaboration with OncoSec

Avacta Group

45.60p

15:44 15/11/24

-1.94%

-0.90p

Avacta Group announced on Monday that it and OncoSec Medical Incorporated have entered into a research collaboration to combine Avacta's ‘Affimer’ protein platform with OncoSec's gene delivery technology ‘ImmunoPulse’.

FTSE AIM All-Share

728.67

15:45 15/11/24

n/a

Pharmaceuticals & Biotechnology

19,259.77

15:45 15/11/24

-2.70%

-535.19

{{ storiesRelated.title }}

Avacta enters research collaboration with OncoSec

Avacta Group

45.60p

15:44 15/11/24

FTSE AIM All-Share

728.67

15:45 15/11/24

Pharmaceuticals & Biotechnology

19,259.77

15:45 15/11/24

You are seeing these quotes based on previous browsing related to sectors such as:

You are seeing these stories as you have shown an interest in the following categories